Also known as Amitiza
Lubiprostone (rINN, marketed under the trade name Amitiza) is a medication used in the management of chronic idiopathic constipation and irritable bowel syndrome. It was approved by the U.S. Food and Drug Administration (FDA) for this purpose on 31 January 2006.Source: Wikipedia
Estimated Total Cost: $190.37 for an average of 28 days supply
Patients are most commonly prescribed lubiprostone to treat chronic constipation, constipation, irritable bowel syndrome, and diverticulosis.